How do you assess the risk of bias in nonrandomized studies?

How do you assess the risk of bias in nonrandomized studies?

• A. Rely on publication status alone.
• B. Only randomized trials require bias assessment.
• C. Bias is not assessed in nonrandomized studies.
• D. Use tools like ROBINS-I or NOS to evaluate confounding, selection bias, measurement bias, and reporting bias.

Answer: (D)

Nonrandomized studies can have systematic differences between groups and measurement issues that distort results, so assessing bias needs a structured approach. Tools like ROBINS-I or the Newcastle-Ottawa Scale provide a clear framework to judge risk of bias across key areas: confounding (could other differences explain the observed effect?), selection bias (how were participants chosen or assigned to groups?), measurement or misclassification of exposures and outcomes, and reporting biases (whether all outcomes were reported). These tools translate how study design and conduct might distort findings into an overall risk-of-bias rating, helping you interpret results with appropriate caution. Relying on publication status alone is insufficient, and bias assessment is essential for nonrandomized designs because the absence of randomization makes bias a central concern in estimating true effects.

Nonrandomized studies can have systematic differences between groups and measurement issues that distort results, so assessing bias needs a structured approach. Tools like ROBINS-I or the Newcastle-Ottawa Scale provide a clear framework to judge risk of bias across key areas: confounding (could other differences explain the observed effect?), selection bias (how were participants chosen or assigned to groups?), measurement or misclassification of exposures and outcomes, and reporting biases (whether all outcomes were reported). These tools translate how study design and conduct might distort findings into an overall risk-of-bias rating, helping you interpret results with appropriate caution. Relying on publication status alone is insufficient, and bias assessment is essential for nonrandomized designs because the absence of randomization makes bias a central concern in estimating true effects.